Lupin Limited has informed the Exchange regarding a press release dated November 03, 2023, titled "Lupin and Zydus Sign Licensing Agreement for Co-marketing Saroglitazar Mg,a critical treatment for chronic liver diseases in India.".
Lupin Limited has informed the Exchange regarding a press release dated November 03, 2023, titled "Lupin and Zydus Sign Licensing Agreement for Co-marketing Saroglitazar Mg,a critical treatment for chronic liver diseases in India.".